nonprofit logo

Rx Drug Access Partnership

Rx Partnership

Learn about this cause: Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 571186937 ✦ Richmond, VA ✦ Designated as a 501(c)(3)

Overview

What is Rx Drug Access Partnership?

Rx Drug Access Partnership is a public-private partnership based in Richmond, Virginia, with a mission to enhance medication access for Virginia's vulnerable populations. This nonprofit organization coordinates the provision of free medications from pharmaceutical companies, credentialing and monitoring nonprofit, licensed pharmacies to distribute these medications directly. In 2023, Rx Drug Access Partnership assisted 30 clinic partners, supporting over 8,342 uninsured Virginians by fulfilling nearly 51,000 prescriptions worth more than $15.3 million. These medications primarily treat chronic illnesses such as asthma, diabetes, hypertension, and depression. The organization serves as a valuable resource for the organizations that support these populations, thereby contributing significantly to healthcare in Virginia.


Official website here: www.rxpartnership.org

Is Rx Drug Access Partnership legitimate?

Rx Drug Access Partnership is a legitimate nonprofit organization registered as a 501(c)(3) entity. Rx Drug Access Partnership submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.

Here are some key statistics you may want to consider:

Executive Compensation: $147,036
Professional Fundraising Fees: $9,750
Other Salaries and Wages: $161,580

For more financial information, click here


Official website here: www.rxpartnership.org

What is the mission statement of Rx Drug Access Partnership?

The Rx Drug Access Partnership is a collaborative initiative aimed at enhancing access to essential medications for vulnerable populations. Acting as a resource for supporting organizations, its primary goal is to increase the availability of these life-sustaining medicines. The partnership coordinates the provision of free medications from pharmaceutical companies, arranging for distribution directly to credentialed, nonprofit pharmacies and clinics without a licensed pharmacy. In fiscal year 2023, the Rx Drug Access Partnership assisted 30 clinic partners, supporting over 8,342 uninsured individuals in Virginia. The medications obtained through this program filled nearly 51,000 prescriptions, valued at over 15.3 million dollars, primarily targeting chronic illnesses such as asthma, diabetes, hypertension, and depression. For every dollar donated to the Rx Drug Access Partnership, an impressive 22 in prescription value was delivered to clinic patients.


Official website here: www.rxpartnership.org

Who is the CEO of Rx Drug Access Partnership?

Amy Yarcich is the Executive Di of Rx Drug Access Partnership.


Official website here: www.rxpartnership.org

What is the revenue of Rx Drug Access Partnership?

Rx Drug Access Partnership's revenue in 2023 was $746,153.


Official website here: www.rxpartnership.org

Who are the executives of Rx Drug Access Partnership and what are their salaries?

The average compensation at Rx Drug Access Partnership during 2023 was $44,088. There are 7 employees and 28 volunteers at Rx Drug Access Partnership.

Here are 17 key members and their salaries:

    Amy Yarcich (Executive Di)
  • Compensation: $130,689
  • Related: $0
  • Other: $19,158

    • Kerri Musselman (Chair) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Dourina Petersen (Vice-Chair) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Shawn Nelson (Treasurer) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Linda Hines (Secretary) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Christine Bryant (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Kevin Christensen (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • David Eastep (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Deborah Hudson (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Rashida Jones (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Sean Keane (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Kathleen Lewis (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Dinesh Pai (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Elizabeth Veliz (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Charlie Webb (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Paul Wesolowski (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Caroline Juran (Ex-Officio) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0


  • Official website here: www.rxpartnership.org

    Where can I find the form 990 for Rx Drug Access Partnership?

    The Rx Drug Access Partnership’s most recent form 990 was submitted in 2023 and can be accessed here


    Official website here: www.rxpartnership.org

    Learn more at the official website: www.rxpartnership.org

    Mission Statement of Rx Drug Access Partnership

    Rx Drug Access Partnership, a public-private collaboration, is dedicated to enhancing medication accessibility for Virginia's vulnerable populations. Acting as a resource for organizations supporting these populations, the partnership's primary objective is to increase the availability of essential medications. By coordinating with pharmaceutical companies, Rx Drug Access Partnership arranges for the distribution of free medications to credentialed, nonprofit pharmacies. Furthermore, the partnership extends its reach to clinics lacking a licensed pharmacy, ensuring medication delivery to a broader range of patients.

    In the fiscal year 2023, Rx Drug Access Partnership provided its 30 clinic partners with access to free medications, supporting over 8,342 uninsured Virginians. The medications obtained through this partnership filled nearly 51,000 prescriptions, with a total value exceeding 15.3 million dollars. These medications primarily addressed chronic illnesses such as asthma, diabetes, hypertension, and depression. The partnership's impact is significant, as for every dollar donated, it delivers 22 dollars worth of prescription value to clinic patients, thereby significantly improving the health outcomes of vulnerable populations in Virginia.

    Impact

    This information is meant to be a general summary of Rx Drug Access Partnership. Please take the time to review official sources before making any decisions based upon the content provided here.




    Saturday, July 20, 2024

    Rx Drug Access Partnership's impact is profound in increasing access to essential medication for Virginia's vulnerable populations. In fiscal year 2023 alone, they provided over 8,342 uninsured Virginians with free medication through their 30 clinic partners. This led to the filling of nearly 51,000 prescriptions valued at more than $15.3 million. The medications distributed by Rx Drug Access Partnership treat chronic illnesses like asthma, diabetes, hypertension, and depression, improving the health outcomes of those in need. For every dollar donated to the organization, $22 in prescription value was delivered to clinic patients, showcasing the efficiency and effectiveness of their programs.





    Financials

    This financial information is from Propublica.

    Revenue
    Expenses
    Efficiency

    Other financial information:

    This information is from the most recently submitted tax form from this organization, which was in 2023.

  • Investment Income: $9,763
  • Program Service Revenue: $67,542
  • Gross Receipts: $921,898

    • Assets and Liabilities:
  • Total Assets: $1,342,893
  • Total Liabilities: $105,892
  • Net Assets: $1,237,001
  • Programs

    Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.

    PROGRAM SERVICE REVENUE

    Revenue

    $67,542

    Organization Details

    Founding Year

    2003

    Principal Officer

    Amy Yarcich

    Main Address

    1500 FOREST AVENUE SUITE 201, RICHMOND, VA, 23229

    NTEE Category

    Code: E60 - Health

    If you are a representative of Rx Drug Access Partnership and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.